Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

5.7K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.7K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of the effectiveness of neoadjuvant chemotherapy versus upfront surgery for osteosarcoma: A target trial emulation study.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same author

Mutational Landscape and Treatment Response in Extensive-Stage Small-Cell Lung Cancer: A Single-Center Real-World Analysis.

Current oncology (Toronto, Ont.)·2026
Same author

Effectiveness and acceptability of different psychotherapies for obsessive-compulsive disorder: network meta-analysis.

The British journal of psychiatry : the journal of mental science·2026
Same author

An artificial intelligence optimized hepatic differentiation unveils NR5A2 and AP-1 transcriptional regulation in hepatic maturation.

The Journal of biological chemistry·2026
Same author

Engineering Mutation Clones in Mammalian Cells with CRISPR/Cas9.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Effectiveness and acceptability of cognitive-behavioural therapy delivery formats for obsessive-compulsive disorder: network meta-analysis - CORRIGENDUM.

The British journal of psychiatry : the journal of mental science·2025
Same journal

Hyocholic acids: Third bile acids for neonatal health.

Trends in molecular medicine·2026
Same journal

Clonal hematopoiesis in Alzheimer's brain: Protective, pathogenic, and context-dependent?

Trends in molecular medicine·2026
Same journal

Targeting amino acid metabolism in hepatocellular carcinoma.

Trends in molecular medicine·2026
Same journal

Turning perfusion into repair through ferroptosis blockade.

Trends in molecular medicine·2026
Same journal

CaMKK2: A tumor stress-integration node.

Trends in molecular medicine·2026
Same journal

Precision gene editing: From proof-of-concept to curative therapies.

Trends in molecular medicine·2026
See all related articles

Related Experiment Video

Updated: Feb 26, 2026

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

9.4K

Osteosarcoma: Molecular Pathogenesis and iPSC Modeling.

Yu-Hsuan Lin1, Brittany E Jewell2, Julian Gingold3

  • 1Department of Integrative Biology and Pharmacology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA; These authors contributed equally to this work.

Trends in Molecular Medicine
|July 25, 2017
PubMed
Summary
This summary is machine-generated.

Rare genetic disorders highlight the role of genes in disease. Patient-derived induced pluripotent stem cells (iPSCs) offer a new way to study osteosarcoma (bone cancer) and develop future therapies.

Keywords:
cancer etiologyfamilial cancer syndromeinduced pluripotent stem cellosteosarcoma

More Related Videos

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

11.6K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.7K

Related Experiment Videos

Last Updated: Feb 26, 2026

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

9.4K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

11.6K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.7K

Area of Science:

  • Genetics
  • Stem Cell Biology
  • Oncology

Background:

  • Hereditary disorders underscore the genetic basis of human diseases.
  • Familial cancer syndromes are crucial for understanding cancer genetics.
  • Osteosarcoma predisposition syndromes offer insights into bone cancer development.

Purpose of the Study:

  • To review osteosarcoma predisposition syndromes.
  • To discuss the utility of induced pluripotent stem cells (iPSCs) in modeling these syndromes.
  • To explore how iPSC models can advance understanding of osteosarcomagenesis and therapy development.

Main Methods:

  • Review of literature on osteosarcoma predisposition syndromes.
  • Analysis of existing induced pluripotent stem cell (iPSC) disease models.
  • Integration of molecular data from iPSC models with osteosarcoma biology.

Main Results:

  • Induced pluripotent stem cells (iPSCs) can successfully model Li-Fraumeni syndrome-associated bone malignancy.
  • iPSCs serve as effective in vitro models for studying osteosarcoma etiology.
  • Established iPSC disease models are available for familial osteosarcoma syndromes.

Conclusions:

  • iPSC disease models are valuable tools for elucidating osteosarcoma pathogenesis.
  • Combining iPSC data with current knowledge deepens understanding of bone cancer mechanisms.
  • This approach holds potential for developing novel patient therapies for osteosarcoma.